RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TODAY’S NUMBERSThanks BlueJays9293 for the interesting and informative reply.
BlueJays9293 wrote: I think regulations would make it really hard for Spectral to sit on that kind of information for very long without disclosing it to shareholders. That's not to say that that kind of deal couldn't happen at any moment in the future, but as of now it's fair to assume that a deal hasn't been agreed to yet.
Have preliminary discussions happened for CG to get a ball park amount that Spectral is seeking? That's more of a grey area in regulations but generally speaking, the moment CG makes an offer to Spectral, the disclosure clock starts ticking, and it only allows for days before it must be disclosed to shareholders. "On-going" negotiations also allows for flexibility on having to disclose but even those must eventually be disclosed.
In my mind, the sweet spot for CG to takeover Spectral, is after the final patient has been enrolled, but before the official release of top line numbers. This sweet spot allows for the Tigris data to be officially locked in, but, before the numbers are released to the world and other interested parties getting wind of it.